Advanced Search

Display
per page
  Report Title Date Provider Type Pgs Price

E-Therapeutics PLC: Business description, financial summary, 3yr and interim financials, key statistics/ratios and historical ratio analysis.

This report is essential reading for any serious investor, providing comprehensive financial information on a company's perfo...

06 Feb 2016 Reuters Investment Profile 12 $20.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

03 Feb 2016 GlobalData 47 $300.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

03 Dec 2015 GlobalData 51 $300.00

Thomson Reuters Stock Report - E-Therapeutics PLC (ETX-LN)

StockReports+ gathers Thomson Reuters independent research, ratings and market data into a single report that optimizes the i...

27 Nov 2015 Thomson Reuters Stock Report 10 $25.00

E-THERAPEUTICS – DISCOVERY PLATFORM COMING TO THE FORE

e-Therapeutics' lead assets, ETS2101 (cancer) and ETS6103 (major depressive disorders), are progressing through clinical tria...

12 Oct 2015 Edison Investment Research 6 $10.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

14 Sep 2015 GlobalData 53 $125.00

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics Plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

16 Jun 2015 GlobalData 53 $125.00

E-THERAPEUTICS - NETWORK PHARMACOLOGY COMING OF AGE

e-Therapeutics is pioneering the concept of network pharmacology, a novel approach that could revolutionise drug discovery. T...

27 Apr 2015 Edison Investment Research 12 $10.00

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review

e-Therapeutics plc (ETX) - Financial and Strategic SWOT Analysis Review Summary e-Therapeutics plc (e-Therapeutics) is a drug...

17 Mar 2015 GlobalData 48 $125.00

E-THERAPEUTICS - ETS2101 PROGRESSING INTO PHASE IB TRIAL

The UK Phase Ia study of ETS2101 in solid tumours has established the maximum tolerated dose (MTD) and reported no serious dr...

15 Jan 2015 Edison Investment Research 4 $10.00